Project Grant HT94252410421
- The U.S. Defense Health Agency awarded a $1,399,917 Project Grant to Ndri-Usa Inc., a non-profit organization based in New York City, under the Military Medical Research and Development program (CFDA 12.420). This 4-year grant, effective April 1, 2025 through March 31, 2029, will support the development of a digital approach to personalizing care, reducing stress, and increasing support for veterans with dementia and their caregivers. Ndri-Usa Inc. has established expertise in conducting...
- Federal Project Grant Award Summary Onward Medical Inc. received a $325,142 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to develop a clinical-grade spinal cord neuroprosthesis designed to alleviate locomotor deficits in individuals with Parkinson's disease. The award, effective September 1, 2025, through August 31, 2028, supports advanced biomedical research and technology development relevant to military and public...
- Federal Project Grant Award Summary Biosensics LLC received a $2.13M Project Grant award from the National Center for Advancing Translational Sciences (NCATS, CFDA 93.350) effective September 1, 2025, through August 31, 2027, to develop and validate HDwear, a wearable sensor platform for remote monitoring of motor impairment in Huntington's Disease (HD) and prodromal HD. The company conducted one of the longest wearable sensor monitoring studies to date, enrolling 41 participants at the...
- The Regents of the University of California, San Francisco will deliver a wearable sensor array for continuous real-time dosimetry for theranostics under a three-year, $1.45 million Project Grant from the Defense Health Agency. The grant is part of the Military Medical Research and Development program (CFDA 12.420), which supports basic, applied, and advanced biomedical research to transform military and public health care through innovative solutions for battlefield medicine. Specifically,...
- Federal Project Grant Summary Aster Labs, Inc. received a $499,943 Project Grant from the National Institute on Aging under the Aging Research program (CFDA 93.866) awarded September 15, 2025, with completion targeted for August 31, 2026. The company will design and develop a novel, unobtrusive wearable sensor system for continuous gait monitoring in older Black adults with Alzheimer's Disease and Related Dementias (ADRD). This device will measure and analyze gait patterns including stride and...
- The Defense Health Agency awarded a $3.755 million Project Grant to the University of Wisconsin-Madison through the Military Medical Research and Development program (CFDA 12.420) to investigate dual orexin antagonist treatment to prevent neurobehavioral sequelae of traumatic brain injury from April 1, 2023 to March 31, 2027. The Military Medical Research and Development program supports innovative medical research to improve warfighter health and transform public healthcare. Under this award,...
- Federal Cooperative Agreement Summary Award Overview Biosensics LLC received a $5.17M Cooperative Agreement from the National Institute on Aging (NIA) under the Aging Research program (CFDA 93.866), effective September 1, 2025 through August 31, 2029. The award supports the development and validation of digital health monitoring technologies to assess motor function decline in Progressive Supranuclear Palsy (PSP) and Dementia with Lewy Bodies (DLB), two severe neurodegenerative conditions that...
- The Defense Health Agency awarded a $2.8 million Project Grant to The Sheba Fund For Health Services And Research (R.a.) under the Military Medical Research and Development program (CFDA 12.420). The grant will support the Department of Defense Alzheimer's Disease Blood-Testing Initiative (DOD-ADBI) from September 2022 to September 2026. The DOD-ADBI study aims to accelerate the development of blood-based diagnostics for Alzheimer's disease among veterans. Specifically, the grantee will...
- This federal Project Grant award for $1,607,403.00, provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports a longitudinal study on monitoring cognitive changes in older veterans using telehealth-based computerized neuropsychological assessments. The award was granted to the East Bay Institute for Research & Education Inc., a non-profit organization in Mather, California, to conduct this 3-year research project from March 1,...
- The Defense Health Agency awarded a $183,258 Project Grant titled "LONGITUDINAL MONITORING OF COGNITIVE CHANGES IN OLDER VETERANS USING TELEHEALTH COMPUTERIZED NEUROPSYCHOLOGICAL ASSESSMENT" to the East Bay Institute for Research & Education Inc. in Mather, CA. The grant is funded under the Military Medical Research and Development program (CFDA 12.420), which supports advanced biomedical research to transform healthcare for military service members, veterans, and the public. The...
The Defense Health Agency awarded a $2,463,953 Project Grant to Biosensics LLC for the development of a "Wearable Sensor Platform for Remote Monitoring of Individuals on the Frontotemporal Dementia Spectrum." The award, made under the Military Medical Research and Development program (CFDA 12.420), will fund the creation of innovative wearable sensor technologies and cloud-based software solutions to enable remote monitoring and management of frontotemporal dementia and related neurodegenerative disorders. Biosensics LLC, a small business specializing in digital health technologies, will leverage its expertise in wearable sensors, mobile applications, and data analytics to advance early detection, monitoring, and interventions for these complex medical conditions. The project, with a performance period of May 1, 2024 to April 30, 2028, aims to improve health outcomes for military personnel, veterans, and the broader public through the development of cutting-edge digital health technologies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $2.5m | 4/22/24 |